-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vipoglanstat in Raynauds Disease
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Vipoglanstat in Raynauds DiseaseDrug Details:vipoglanstat (GS-248, OX-MPI) is under development for the treatment of Raynaud's disease...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vipoglanstat in Raynauds Disease
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Vipoglanstat in Raynauds Disease Drug Details: Vipoglanstat (GS-248, OX-MPI) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vipoglanstat in Systemic Sclerosis (Scleroderma)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Vipoglanstat in Systemic Sclerosis (Scleroderma) Drug Details: Vipoglanstat (GS-248, OX-MPI) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vipoglanstat in Systemic Sclerosis (Scleroderma)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Vipoglanstat in Systemic Sclerosis (Scleroderma)Drug Details:vipoglanstat (GS-248, OX-MPI) is under development for the treatment of Raynaud's...
-
Track & Monitor
Artificial intelligence in pharma: AI in multiomics
Why settle for outdated information when you can stay ahead of the curve with our comprehensive report? Our team of industry experts has meticulously researched and analyzed the latest trends, innovations, and emerging technologies in the pharma industry’s AI in multiomics within Artificial intelligence innovations. By leveraging our report, you'll gain invaluable insights that can revolutionize your business strategies and give you a competitive edge. Why Choose Our Report? Unparalleled Expertise: Our research team consists of seasoned analysts with deep...
-
Product Insights
MPI Vietnam – The National Innovation Center – Ha Noi
Equip yourself with the essential tools needed to make informed and profitable decisions with our MPI Vietnam - The National Innovation Center - Ha Noi report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
MPI Group – 294 Sherbourne Student Housing Complex – Ontario
Equip yourself with the essential tools needed to make informed and profitable decisions with our MPI Group - 294 Sherbourne Student Housing Complex - Ontario report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
MPI Vietnam – Dong Dang Border Gate Economic Zone – Lang Son
Equip yourself with the essential tools needed to make informed and profitable decisions with our MPI Vietnam - Dong Dang Border Gate Economic Zone - Lang Son report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
MPI Vietnam – Thanh Phu Residential Development – Long An
Equip yourself with the essential tools needed to make informed and profitable decisions with our MPI Vietnam - Thanh Phu Residential Development - Long An report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Medco Power Indonesia/ Pertamina Geothermal – PGE/MPI Geothermal Power Plant 495 MW – Indonesia
Equip yourself with the essential tools needed to make informed and profitable decisions with our Medco Power Indonesia/ Pertamina Geothermal - PGE/MPI Geothermal Power Plant 495 MW - Indonesia report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the...